Location History:
- Duarte, CA (US) (2018)
- Los Angeles, CA (US) (2017 - 2019)
- Culver City, CA (US) (2019 - 2022)
Company Filing History:
Years Active: 2017-2022
Title: Kevin Ferreri: Innovator in Beta Cell Research
Introduction
Kevin Ferreri is a notable inventor based in Culver City, CA (US). He has made significant contributions to the field of medical research, particularly in the area of beta cell death measurement. With a total of 5 patents to his name, Ferreri's work is paving the way for advancements in diabetes research and treatment.
Latest Patents
Ferreri's latest patents include innovative methods and compositions for measuring beta cell death. These patents provide nucleic acids, methods, and kits for detecting unmethylated DNA in body fluid samples of subjects. The disclosures also encompass compositions, methods, and kits for detecting unmethylation at a CpG site in an insulin gene promoter of a subject. This research is crucial for understanding and potentially mitigating the effects of diabetes.
Career Highlights
Kevin Ferreri is currently associated with City of Hope, a leading research and treatment center. His work at this institution has allowed him to focus on groundbreaking research that has the potential to change the landscape of diabetes treatment. His dedication to innovation in this field is evident through his numerous patents and ongoing research efforts.
Collaborations
Ferreri collaborates with esteemed colleagues such as Mohamed I Husseiny Elsayed and Yun Yen. These partnerships enhance the quality and impact of his research, fostering an environment of innovation and discovery.
Conclusion
In summary, Kevin Ferreri is a distinguished inventor whose work in beta cell research is making significant strides in the medical field. His contributions through patents and collaborations are vital for advancing our understanding of diabetes and improving patient outcomes.